Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tumor-type specific methylation patterns of MTAP in human samples and cell lines.

Clinical epigenetics·2026
Same author

UCA1 copy number gain in serum cfDNA predicts next-generation antiandrogen resistance in metastatic castration-resistant prostate cancer.

Scientific reports·2026
Same author

Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.

NPJ precision oncology·2026
Same author

Site-dependent Treg cell transcriptional reprogramming in a metastatic colorectal cancer model holds prognostic significance.

Cancer letters·2026
Same author

All screens lead to polo-like kinase 1: A central node in cancer therapeutics and resistance.

Pharmacological research·2026
Same author

Functional germline variants together with somatic mutations alter the integrity of cancer hallmark regulatory networks.

Genome medicine·2026

相关实验视频

Updated: Jun 9, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K

基于基因表达的乳腺癌纯度评分的开发和验证.

Marco Barreca1,2, Matteo Dugo3, Barbara Galbardi3

  • 1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.

NPJ precision oncology
|October 25, 2024
PubMed
概括
此摘要是机器生成的。

一个新的9基因乳腺癌纯度评分 (BCPS) 准确地估计了乳腺癌样本中的瘤纯度. 这一分数有助于减少分子数据分析中的偏见,并改善癌症预后和治疗反应预测.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.2K

相关实验视频

Last Updated: Jun 9, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.2K

科学领域:

  • 在瘤学瘤学.
  • 基因组学就是基因组学.
  • 生物信息学是一种生物信息学.

背景情况:

  • 瘤纯度,恶性细胞的比例,影响了批量样本的分子分析.
  • 瘤纯度的变化在数据分析和解释中引入了偏差.
  • 估计瘤纯度的现有方法缺乏乳腺癌的特异性.

研究的目的:

  • 开发和验证一种新的,乳腺癌特定的方法来估计瘤纯度.
  • 与现有技术相比,评估新方法的性能.
  • 评估新得分在改善分子数据解释和临床预后方面的有用性.

主要方法:

  • 采访了来自10个不同乳腺癌数据集的6000多个表达特征.
  • 开发和验证一个9基因乳腺癌纯度评分 (BCPS).
  • 对BCPS与现有的瘤纯度估计方法进行比较分析.

主要成果:

  • 与现有方法相比,开发的BCPS在估计瘤含量方面表现优异.
  • 使用BCPS调整转录组资料有效减少了采样偏差,并有助于数据解释.
  • 根据BCPS估计的瘤纯度显示,光线乳腺癌的预后有所改善.
  • 在三阴性乳腺癌患者中,BCPS与病理完整反应相关.
  • 在HER2+残留疾病中,BCPS分层复发风险在新辅助治疗后.

结论:

  • 9基因BCPS是一种强大而准确的工具,用于估计乳腺癌的瘤纯度.
  • 在大型临床队列中,BCPS促进了更可靠的分子数据分析和解释.
  • 应用BCPS增强了临床预后和预测各种乳腺癌亚型的治疗结果.